Skip to main content

Estimating the Positive Benefits of Schedule 3 Consumer Advertising

Project Member(s): Goodall, S., Street, D., Viney, R., Haas, M.

Funding or Partner Organisation: Australian Self Medication Industry

Start year: 2015

Summary: This project will develop a research program for the Australian Self Medication Industry Inc (ASMI) that explores the impact of Schedule 3 consumer advertising, including any potential benefits to consumers. This project involves the development, design and analysis of complex discrete choice models; and the collection of data through a number of web-based surveys. The major costs are in personnel, and the data collection through on-line recruitment and survey administration.

Publications:

Meshcheriakova, O, Goodall, S, Street, D & Viney, R 2019, 'Does the price premium for branded medicines reflect preferences? A case study from Australia', 11th Meeting of the International Academy of Health Preference Research, Auckland, New Zealand.

Goodall, S, Zhao, F-L, Street, D & Viney, R 2016, 'Estimating the impact of direct-to-consumer advertising of pharmacy only medicines using discrete choice experiments', Value in Health, ISPOR 7th Asia-Pacific Conference, Elsevier, Singapore, pp. A855-A855.
View/Download from: Publisher's site

Keywords: pharmacist only medicine, discrete choice experiment

FOR Codes: Health Economics, Health Policy Economic Outcomes, Health Policy Evaluation